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Abstract
Extinction risks are increasing for amphibians due to rising threats and minimal conservation efforts. Nearly one quarter of
all threatened/extinct amphibians in the IUCN Red List is purportedly at risk from the disease chytridiomycosis. However, a
closer look at the data reveals that Batrachochytrium dendrobatidis (the causal agent) has been identified and confirmed to
cause clinical disease in only 14% of these species. Primary literature surveys confirm these findings; ruling out major
discrepancies between Red List assessments and real-time science. Despite widespread interest in chytridiomycosis, little
progress has been made between assessment years to acquire evidence for the role of chytridiomycosis in species-specific
amphibian declines. Instead, assessment teams invoke the precautionary principle when listing chytridiomycosis as a threat.
Precaution is valuable when dealing with the world’s most threatened taxa, however scientific research is needed to
distinguish between real and predicted threats in order to better prioritize conservation efforts. Fast paced, cost effective, in
situ research to confirm or rule out chytridiomycosis in species currently hypothesized to be threatened by the disease
would be a step in the right direction. Ultimately, determining the manner in which amphibian conservation resources are
utilized is a conversation for the greater conservation community that we hope to stimulate here.
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Introduction
Recent research has suggested that extinction risks are increasing
for vertebrates due to high levels of threat coupled with unsuccessful
conservation efforts to mitigate species loss [1–4]. Of particular
concern are amphibians, approximately 41% of which are classified
as ‘threatened’ (e.g. vulnerable, endangered or critically endan-
gered) by the International Union for Conservation of Nature Red
List (IUCN Red List) [4,5]. A 2010 synthesis of the Red List
concluded that amphibiansaremore threatened than eitherbirds or
mammals with index values (aggregated measures of extinction risk)
declining more than three percent from 1980 to 2004; a
deterioration equivalent to 662 species each moving one Red List
category closer to extinction during this time [4].
The decline of amphibians is among the world’s most
compelling conservation issues [3,6,7] and the disease chytridio-
mycosis, caused by the fungal pathogen Batrachochytrium dendroba-
tidis (Bd), is widely believed to play a role in these declines due to its
rapid spread, global distribution, broad diversity of host species,
and high virulence [3,6,8–11]. In Latin America alone, Bd has
been implicated in the possible extinctions of ,27% of the region’s
113 species of Atelopus harlequin toads [11,12]. To conserve
amphibians from chytridiomycosis and other threats, scientists
have called for action plans similar to those that have been
effective for birds and mammals [4]. Though nearly all threatened
species are at risk from multiple causal factors, the most successful
conservation actions have explicitly targeted individual threats:
invasive species eradications from islands to save birds and
mammals from non-native predators [13,14], site-specific hunting
bans to preserve birds in Brazil, and international legislation to
protect marine mammals, like the Vicun ˜a, from bycatch [4,15,16].
Designing focused action plans like these is a complex and case-
specific process that relies heavily on scientific evidence to validate
threats and quantify the magnitude of impact. The IUCN Red List
represents the worldwide standard for evaluating extinction risks
[17,18] and has been used repeatedly to assess the impact of
individual and multiple threats in the loss of global diversity and
for specific taxonomic groups [19–21].
In 2006, Smith et al. [21] found evidence of disease in only
,11% of then extinct, extinct in the wild, and critically
endangered amphibians reported by the Red List as threatened
by a pathogen or parasite (Fig. 1). Re-analysis of the Red List four
years later indicates that little progress has been made to confirm
the causal role of disease, specifically chytridiomycosis, in the
global loss of amphibians. We present these new findings here and
discuss the implications for amphibian conservation.
Methods
We repeated the analyses of Smith et al. 2006 [21], individually
examining the ‘‘full account’’ of amphibian species assessments in
the 2010 Red List to determine those threatened by infectious
disease, specifically chytridiomycosis and/or the causal agent Bd.
Smith et al. ’s 2006 [21] data included amphibians threatened
generally by disease (the authors did not distinguish those
threatened by chytridiomycosis, though the pathogen was the
likely cause). Data compiled for this study includes only amphibian
species specifically threatened by chytridiomycosis/Bd but these
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in the Red List. Whereas Smith et al. [21] only examined species
extinct, extinct in the wild and critically endangered, we examined
these status categories as well as endangered and vulnerable.
Data was compiled from the Red List in June–August 2010
resulting in 432 amphibian species with disease reported as a
threat in the full account. Eleven species had pathogens other than
Bd listed as the disease agent of concern or reported the threat of a
‘disease’ but did not specify which. These were excluded from
analyses (CR: Rhinella amabilis, Ecnomiohyla rabborum, Ambystoma
mexicanum; EN: Atelognathus patagonicus, Atelopus oxapampae; VU:
Batrachuperus pinchonii, Prestimantis schultei, Rana draytonii, Rana latastei,
Cochranella punctulata, Rhinella quechua.) The 421 remaining amphib-
ian species assessments explicitly listed threat from the disease
chytridiomycosis or the pathogen Bd and were therefore the basis
for our analyses (Table S1).
Each species account was read in full and species assigned to
one of two categories based on level of evidence in support of a
chytridiomycosis/Bd threat:
1) Evidence for Chytridiomycosis: chytridiomycosis is a con-
firmed threat and/or the fungus Bd has been identified in at
least one of the species’ populations where it is confirmed to
cause disease.
2) Chytridiomycosis Hypothesized: no evidence exists to support
chytridiomycosis as a threat, Bd has not been detected in any
of the species’ populations, Bd has been hypothesized to
threaten the species in the future, or the species is determined
asymptomatic when infected.
We determined the proportion of amphibian species that
deteriorated in Red List status by three or more categories from
1980–2004 that are purportedly threatened by chytridiomycosis/
Bd. Amphibian species that deteriorated in status by more than
three categories were identified using data collected by Hoffmann
et al. [4] (Table S2). We focused on amphibian species that
deteriorated by three or more categories because they are
considered the most threatened and are likely to have garnered
significant attention from the scientific community. For each
amphibian species, we also examined whether there was evidence
confirming the purported threat of chytridiomycosis/Bd.
We utilized the 2010 Red List for our analyses, however, data on
several species had not been updated since 2004, increasing the
potential for a significant discrepancy between real-time science
(specifically publications after 2004) and Red List assessment status.
To test for this, we conducted advanced literature surveys of the 123
amphibian species last assessed in 2004 as critically endangered and
hypothesized to be threatened by chytridiomycosis/Bd to determine
Figure 1. Proportion of amphibian species with disease reported as a threat by the Red List, distinguished by those with
supporting evidence and those where disease is only hypothesized. Extinct (Ex) and Extinct in the Wild (ExW) pooled, Critically Endangered
(CR), Endangered (EN) and Vulnerable (VU). 2006 data is adapted from Smith et al. [21] and includes amphibians threatened generally by disease (not
distinguishing those threatened by chytridiomycosis/Bd). 2010 data includes amphibians specifically threatened by chytridiomycosis/Bd (97% of
disease-threatened amphibian species). Only two species account for the 2006–2010 increase in the proportion of Ex/ExW amphibians with evidence
of disease/chytridiomycosis: Anaxyrus baxteri and Nectophrynoides asperginis are both extinct in the wild, each having natural populations with
confirmed presence of Bd since 2006). Evidence for Chytridiomycosis: chytridiomycosis is a confirmed threat and/or the fungus Batrachochytrium
dendrobatidis (Bd) has been reported in at least one of the species’ populations and not confirmed as non-pathogenic. Chytridiomycosis
Hypothesized: no evidence exists to support chytrid as a threat, Bd has not been detected in the species, or the species is determined asymptomatic
when infected.
doi:10.1371/journal.pone.0023150.g001
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but were not yet incorporated into Red List assessments (Table S3).
We searched for published primary literature in Google Scholar
(validated against Web of Science and PubMed) using the following
search strings: scientific name chytridiomycosis, common name
chytridiomycosis, scientific name Batrachochytrium dendrobatidis, com-
mon name Batrachochytrium dendrobatidis. Each article returned was
read in full to identify inconsistencies with evidence level reported
for each of the 123 species hypothesized by the Red List to be
threatened by chytridiomycosis/Bd.
Results
In 2006, Smith et al. [21] found evidence of disease in only
,11% of then extinct, extinct in the wild, and critically
endangered amphibians reported by the Red List as threatened
by a pathogen or parasite (Fig. 1). Re-analysis of the Red List four
years later indicates that little progress has been made to confirm
the causal role of disease, specifically chytridiomycosis, in the
global loss of amphibians (Fig. 1). Of 421 Red List amphibian
species purportedly threatened by chytridiomycosis, evidence that
Bd has been identified in the species and confirmed to cause
clinical disease exists for only fifteen percent (Fig. 1). Of the 36
amphibian species reported by Hoffmann et al. to have
deteriorated by three or more Red List categories from 1980–
2004, the majority are purportedly threatened by chytridiomycosis
(28 species), but only 39% of these are backed by scientific
evidence (Table S2). Advanced primary literature surveys on the
123 critically endangered amphibian species last assessed by the
Red List in 2004 identified 751 Google Scholar search results
concerning these species (Table S3). Within these results we found
evidence confirming Bd infections for only ten species.
Discussion
The lack of scientific evidence to support the listing of
chytridiomycosis as a threat to 358 Red Listed amphibians
(Fig. 1; Table S1) is surprising given the magnitude of attention the
disease received in the last decade. Analyses comparing Red List
assessments with the primary literature rule out major discrepan-
cies with real-time science. Of the 123 hypothesized chytridiomy-
cosis-threatened critically endangered amphibians reviewed, only
ten had confirmed Bd infections reported in the primary literature.
Of these only five had evidence that the fungus ultimately caused
chytridiomycosis (Table S3). This is consistent with a growing
body of research suggesting that many species harbor Bd but never
develop chytridiomycosis or experience resulting population
declines (i.e. the North American bullfrog Rana catesbeiana)
[11,22–24]. The high proportion of Red List amphibians with a
purported chytridiomycosis threat not backed by scientific
evidence implies a strong precautionary approach adopted by
assessment teams. Erring on the side of caution can be critical to
conservation and so Red List assessments often include hypoth-
esized or future threats deemed likely to have irreversible effects
[21,25]. As was the finding of Smith et al. [21], precaution
continues to drive the listing of chytridiomycosis as a threat to
many Red Listed amphibians. The precautionary principle is valid
approach when dealing with the world’s most threatened
vertebrate taxa, but focused scientific efforts to distinguish between
real and hypothesized threats should be a larger priority.
In the four and a half years since Smith et al. ’s [21] analyses,
$4,119,851 in awarded NSF grants, £1,617,371 in awarded UK
Research Council grants, and 249 publications have been
dedicated to chytridiomycosis research [26,27]. In addition, the
Office Internationale des Epizooties (OIE) recognized chytridio-
mycosis as a reportable threat to wildlife, the Amphibian Survival
Alliance was formed, and the U.S. Pet Industry Joint Advisory
Council implemented their Bd-Free ‘Phibs campaign. Despite a
wealth of science, policy and industry efforts like these, our
findings reveal that little progress has been made to acquire
science-based evidence on the role of chytridiomycosis in species-
specific amphibian declines. The recent IUCN Amphibian
Conservation Action Plan (ACAP) should help to fill this
knowledge gap, calling for an ambitious US $25 million 5-year
chytridiomycosis research agenda with studies targeted to 1) sites
where amphibians are undergoing enigmatic declines due to the
disease, and 2) sites where Bd is present, yet populations of
amphibians persist without declines [28]. If chytridiomycosis is as
serious a threat as ACAP suggests, and most experts believe,
knowing which species it will harm is equally critical to prioritizing
amphibian conservation efforts. Determining this for each of the
,350 species hypothesized to be threatened by the disease, or
predicated to be in the future, is unrealistic. However, a step in the
right direction would be prioritizing select species with a
hypothesized chytridiomycosis threat for in situ studies that
provide evidence of disease presence, or rule it out. The success
of broad surveys like this would depend on cost effect and rapid
diagnostic techniques. Such studies, especially those focused on
qPCR in preserved and field collected specimens, have already
proven successful in accumulating species-specific data on Bd
presence and chytridiomycosis effects at the population scale
[11,29–34]. Support to continue this level of research would go a
long way toward shoring up the science behind Red List
assessments and subsequently prioritize amphibian conservation.
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